LBF20115PG03: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
|LipidBank=XPR1720 | |LipidBank=XPR1720 | ||
|LipidMaps=LMFA03010027 | |LipidMaps=LMFA03010027 | ||
|SysName=(9alpha,11alpha) -Dihydroxy-15-oxo-prost- | |SysName=(9alpha,11alpha) -Dihydroxy-15-oxo-prost-5-cis-en-1-oic acid | ||
|Common Name=&&13,14-dihydro-15-keto Prostaglandin F_2alpha&& | |Common Name=&&13,14-dihydro-15-keto Prostaglandin F_2alpha&&(9alpha,11alpha) -Dihydroxy-15-oxo-prost-5Z-en-1-oic acid&& | ||
|Source=13,14-dihydro-15-keto PGF2 alpha is the first prominent plasma metabolite of PGF2 alpha via PG 15-dehydrogenase pathway.[[Reference:Samuelsson_B:Goldyne_M:Granstrom_E:Hamberg_M:Hammarstrom_S:Malmsten_C:,Annu. Rev. Biochem.,1978,47,997|{{RelationTable/GetFirstAuthor|Reference:Samuelsson_B:Goldyne_M:Granstrom_E:Hamberg_M:Hammarstrom_S:Malmsten_C:,Annu. Rev. Biochem.,1978,47,997}}]] | |Source=13,14-dihydro-15-keto PGF2 alpha is the first prominent plasma metabolite of PGF2 alpha via PG 15-dehydrogenase pathway.[[Reference:Samuelsson_B:Goldyne_M:Granstrom_E:Hamberg_M:Hammarstrom_S:Malmsten_C:,Annu. Rev. Biochem.,1978,47,997|{{RelationTable/GetFirstAuthor|Reference:Samuelsson_B:Goldyne_M:Granstrom_E:Hamberg_M:Hammarstrom_S:Malmsten_C:,Annu. Rev. Biochem.,1978,47,997}}]] | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
Revision as of 02:11, 27 May 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1720 |
| LipidMaps | LMFA03010027 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20115PG03 |
| 13,14-dihydro-15-keto Prostaglandin F_2α | |
|---|---|
| |
| Structural Information | |
| (9α,11α) -Dihydroxy-15-oxo-prost-5-cis-en-1-oic acid | |
| |
| Formula | C20H34O5 |
| Exact Mass | 354.240624198 |
| Average Mass | 354.48096000000004 |
| SMILES | C(CCC(=O)CC[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
| Physicochemical Information | |
| 13,14-dihydro-15-keto PGF2 alpha is the first prominent plasma metabolite of PGF2 alpha via PG 15-dehydrogenase pathway. Samuelsson_B et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
